Patent details

EP3463432 Title: LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3463432
WO Application Number:
EP2017062785
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17728095.5
WO Publication Number:
WO2017203038
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
26/05/2017
Grant date:
07/10/2020
EP Publication Date:
10/04/2019
WO Publication Date:
30/11/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
23/12/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/10/2020
EP B1 Publication Date:
07/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
25/05/2037
Lapsed By Expiration Date:
Patent Validated Date:
13/01/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/02/2023
 
 

 

Name:
Galderma Holding SA
Address:
Zählerweg 10, 6300, Zug, Switzerland (CH)

From:
04/05/2021
 
 

 

Name:
Ipsen Biopharm Limited
Address:
Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom (GB)

Historical Applicant/holder

From:
04/05/2021
To:
22/02/2023

 

Name:
Galderma Holding SA
Address:
Rue d'Entre-deux-Villes, 10, 1814, La Tour-de-Peilz, Switzerland (CH)

From:
07/10/2020
To:
04/05/2021

 

Name:
Ipsen Biopharm Limited
Address:
Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom (GB)

From:
07/10/2020
To:
04/05/2021

 

Name:
Nestlé Skin Health SA
Address:
Avenue Gratta-Paille 2, 1018 Lausanne, Switzerland (CH)

Agent

Name:
ir. F.A. Geurts c.s.
From:
12/01/2021
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
JARSTAD, Anders
Address:
756 48 Uppsala, Sweden (SE)

2

Name:
FRIIS, Anna
Address:
755 98 Uppsala, Sweden (SE)

3

Name:
STAHL, Ulf
Address:
75324 Uppsala, Sweden (SE)

4

Name:
GURELL, Ann
Address:
113 35 Stockholm, Sweden (SE)

5

Name:
AGREN, Barbro
Address:
830 02 Mattmar, Sweden (SE)

6

Name:
EDSTROM, Emilia
Address:
75264 Uppsala, Sweden (SE)

7

Name:
PICKETT, Andrew
Address:
757 57 Uppsala, Sweden (SE)

Priority

Priority Patent Number:
PCT/EP2016/062085
Priority Date:
27/05/2016
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 8/19; A61K 8/39; A61K 8/49; A61K 8/66; A61K 9/00; A61K 31/405; A61K 31/506; A61K 38/48; A61K 47/02; A61K 47/26; A61P 5/00; A61P 13/00; A61P 19/00; A61P 19/02; A61P 25/00; A61P 27/02; A61P 29/00; A61Q 19/08; A61K 47/18;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
24/21
Publication date:
16/06/2021
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
02/21
Publication date:
13/01/2021
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
41/20
Publication date:
07/10/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202041
Publication date:
07/10/2020
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202300429A
Date Registered:
22/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202100925A
Date Registered:
04/05/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Ipsen Biopharm Limited
Address:
Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom (GB)

2

Name:
Galderma Holding SA
Address:
Rue d'Entre-deux-Villes, 10, 1814, La Tour-de-Peilz, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/05/2025
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
23/05/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Octrooibureau Vriesendorp&Gaade BV
Filing date Document type Document Description Number of pages File Type
12/01/2021 Outgoing Correspondence Letter no formal defects 1 PDF /2/7/9/8/0/0800608972/docs/ep17728095.5_0_388699l271.pdf
23/12/2020 Claims First filed claims 3 PDF /2/7/9/8/0/0800608972/docs/ep17728095.5_1_claims20201223154726021.pdf